Navigation Links
Positive Results for Investigational Compound Lyxumia® (Lixisenatide) Presented at American Diabetes Association's 71st Annual Scientific Sessions
Date:6/24/2011

acy and safety for lixisenatide. Further results are expected during 2011.

About DiabetesDiabetes is a chronic, widespread condition characterized by high blood sugar in which the body does not produce or properly use insulin, the hormone needed to transport glucose (sugar) from the blood into the cells of the body for energy. It is estimated that approximately 285 million adults worldwide are living with the disease and this number is expected to rise to a staggering 438 million within 20 years.  It is estimated  that nearly 26 million  Americans have diabetes, including an estimated 7 million who remain undiagnosed.  At the same time, approximately 40 percent of those diagnosed  with  diabetes  did  not  achieve  the  blood  sugar  control  target  of  A1C  <7  percent recommended by the  American Diabetes Association. The A1C test measures average blood glucose levels over the past two-to-three-month period.

About the Sanofi Diabetes DivisionSanofi strives to help people manage the complex challenges of diabetes by delivering innovative, integrated and personalized solutions.  Driven by valuable insight that comes from listening to and engaging with people living with diabetes, the Company is forming partnerships to offer diagnostics, therapies, services, and devices.  Sanofi markets both injectable and oral medications for people with type 1 or type 2 diabetes.  Investigational compounds in the pipeline include an injectable GLP-1 agonist being studied as a single agent, in combination with basal insulins, and/or in combination with oral antidiabetic agents.

About SanofiSanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines,
'/>"/>

SOURCE Euro RSCG Life
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
3. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
4. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
5. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
6. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
7. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
8. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
9. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
10. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
11. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... -- An international roster of experts on malignant pleural mesothelioma ... Santa Monica, Calif. , to discuss their latest ... rare form of cancer that results from exposure to ... the chest. Hosted by UCLA and the ... International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma ...
(Date:5/24/2013)... Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a leading provider ... Robert Grieve , the Company,s chairman and ... executive vice president and chief financial officer, will present at ... May 30, 2013 in New York City ... Company,s presentation is scheduled to begin at 1:30 p.m. EDT. ...
(Date:5/24/2013)... BEIJING , May 24, 2013 China ... "Company"), a leading fully integrated plasma-based biopharmaceutical company in ... Company has recently learned from a public announcement issued ... a public company listed on Shenzhen Stock Exchange, that ... Chan ("Ms. Chan"), one of the shareholders ...
Breaking Medicine Technology:International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4
... Tongjitang Chinese Medicines Company (the "Company" or "Tongjitang") (NYSE: ... focusing on the development, manufacturing, marketing and selling of ... it plans to release its fourth quarter and full ... March 25, 2011. Tongjitang,s management team will ...
... MADISON, N.J., March 21, 2011 Quest Diagnostics ... provider of diagnostic testing, information and services, announced ... aggregate principal amount of four series of senior ... shelf registration statement filed with the Securities and ...
Cached Medicine Technology:Tongjitang Chinese Medicines Company to Announce Fourth Quarter and Full Year 2010 Financial Results 2Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering 2
(Date:5/24/2013)... new neurons in the hippocampus - a brain region ... could cause forgetting of old memories by causing a ... and Sheena Josselyn, both from the Hospital for Sick ... positive effect of clearing old memories, reducing interference and ... were presented at the 2013 Canadian Neuroscience Meeting, the ...
(Date:5/24/2013)... New York, NY (PRWEB) May 24, 2013 ... has granted Cellular Dynamics International (CDI) exclusive license rights ... cell therapy and regenerative medicine applications. These cells are ... of the heart, including cardiomyocytes, endothelial cells, and vascular ... a potential therapeutic for damaged heart tissue. , The ...
(Date:5/24/2013)... On May 16, students, family members, and ... American University of Antigua (AUA) College of Medicine ... was the largest graduating class to date. The ceremony ... Vice President for Enrollment Management and Chief Operating Officer, ... Dean of Students and Professor and Chair – Physiology, ...
(Date:5/24/2013)... 2013 The creative flair and design ... University (PolyU)'s Institute of Textiles and Clothing (ITC) have ... Fashion Show held on 22 May at The Mira ... of ITC design students, various knitwear producers and yarn ... collections of four outfits from 20 graduating students majoring ...
(Date:5/24/2013)... THURSDAY, May 23 (HealthDay News) -- Type 2 diabetes ... of serious complications seen just a few years after ... latest results, it seems like type 2 is progressing ... vice president of medical affairs and community information for ... it appears to be at a more significant rate ...
Breaking Medicine News(10 mins):Health News:New neuron formation could increase capacity for new learning, at the expense of old memories 2Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 2Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 3Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 4Health News:AUA Celebrates Seventh Annual Commencement Ceremony 2Health News:PolyU Stages Knitwear Fashion Show 2Health News:Type 2 Diabetes Progresses Faster in Kids, Study Finds 2Health News:Type 2 Diabetes Progresses Faster in Kids, Study Finds 3
... Tragedy: The mass shooting in Tucson that ... Congresswoman Gabrielle Giffords, brought significant attention to ... mental, emotional and behavioral disorders (MEBs) and substance abuse. ... be answered by a panel of experts, including Ron ...
... promising cancer treatment drug can restore function of a heart ... UT Southwestern Medical Center have found. The drug, a ... ongoing clinical trials, has been shown to reverse the harmful ... is a natural process by which cells eat their own ...
... enzyme associated with extensive antibiotic resistance called New Delhi ... worldwide, has been found in two people in the ... states a case report in CMAJ ( ... http://www.cmaj.ca/embargo/cmaj110477.pdf . The report outlines challenges and approaches to ...
... May 29 (HealthDay News) -- Attacks by North American black ... rising as the human population of the United States and ... in the Journal of Wildlife Management , also dispels ... mothers with cubs to protect. Researchers reveal that lone male ...
... -- Native American children in the United States and Canada ... other kids, according to a new policy statement from a ... oral health of those patients. A survey of 2,633 ... the United States, Alaska and Canada found that 68 percent ...
... symptoms is distressing for both patient and doctor and ... five patients have symptoms that remain unexplained by conventional ... NHS of managing the treatment of a patient with ... patient with a diagnosis. A research team ...
Cached Medicine News:Health News:Tucson tragedy; college athletes and drinking; depression in adolescents; and yoga and drug use 2Health News:Drug can reverse overgrown hearts to help prevent heart failure, UT Southwestern researchers find 2Health News:New Delhi metallo-beta-lactamase-1 enzyme acquired in Canada 2Health News:Fatal Black Bear Attacks Rare But Rising 2Health News:Native American Children Have More Tooth Decay 2Health News:Acupuncture of benefit to those with unexplained symptoms 2Health News:Acupuncture of benefit to those with unexplained symptoms 3
... early 1990s, the "Reversed" shoulder prosthesis has ... great success. More recently, an ever-growing number ... begun to champion this prosthesis and the ... This reversed technology is the result of ...
... spectrofluorometer is the ... among the FLUORAT®-02 ... intended for scientific ... and for operation ...
... The Gemini XPS spectrofluorometer ... measurements as required by ... assays. Cellular and molecular ... drug screening, and SNP ...
The FluoroMax-3 is the entry level spectrofluorometer from Spex®, yet offers features not found in most of the top models of the competition....
Medicine Products: